AstraZeneca's Strategic Move: Strengthening Ties with China
UK-based pharmaceutical giant AstraZeneca has unveiled plans for a substantial $15 billion investment in China over the next seven years. The investment is aimed at enhancing the company's drug manufacturing.....
Subscribe for Full Access!
Gain valuable sourcing and trade intelligence from our database of millions of data points spanning 20+ years!
